MDMA,
called "Adam," "ecstasy," or "XTC"
on the street, is a synthetic, psychoactive (mind-altering)
drug with hallucinogenic and amphetamine-like properties.
Its chemical structure (3-4 methylenedioxymeth- amphetamine)
is similar to two other synthetic drugs, MDA and
methamphetamine, which are known to cause brain damage.
Beliefs
about MDMA are reminiscent of similar claims made about LSD
in the 1950s and 1960s, which proved to be untrue. According
to its proponents, MDMA can make people trust each other and
can break down barriers between therapists and patients,
lovers, and family members.
Health
Hazards
Many
problems users encounter with MDMA are similar to those
found with the use of amphetamines and cocaine. They are as
follows:
Psychological
difficulties, including confusion, depression, sleep
problems, drug craving, severe anxiety, and paranoia
during and sometimes weeks after taking MDMA. (Even
psychotic episodes have been reported.)
Physical
symptoms such as muscle tension, involuntary teeth
clenching, nausea, blurred vision, rapid eye movement,
faintness, and chills or sweating.
Increases
in heart rate and blood pressure, a special risk for
people with circulatory or heart disease.
Recent
research findings also link MDMA use to long-term damage to
those parts of the brain critical to thought and memory. It
is thought that the drug causes damage to the neurons that
use the chemical serotonin to communicate with other
neurons. In monkeys, exposure to MDMA for four days caused
brain damage that was evident six to seven years later. This
study provides further evidence that people who take MDMA
may be risking permanent brain damage.
Also,
there is evidence that people who develop a rash that looks
like acne after MDMA use may be risking severe side effects,
including liver damage, if they continue using.
MDA,
the parent drug of MDMA, is an amphetamine-like drug that
has also been abused and is similar in chemical structure to
MDMA. Research shows that MDA destroys serotonin-producing
neurons, which play a direct role in regulating aggression,
mood, sexual activity, sleep, and sensitivity to pain. It is
probably this action on the serotonin system that gives MDA
its purported properties of heightened sexual experience,
tranquillity, and conviviality.
MDMA
also is related in structure and effects to methamphetamine,
which has been shown to cause degeneration of neurons
containing the neurotransmitter dopamine. Damage to these
neurons is the underlying cause of the motor disturbances
seen in Parkinsons disease. Symptoms of this disease begin
with lack of coordination and tremors, and can eventually
result in a form of paralysis.
Extent
of Use
Community
Epidemiology Work Group (CEWG)
MDMA
is used most often by young adults and adolescents at clubs,
raves (large, all-night dance parties), and rock concerts.
Its
abuse is increasingly reported in the 20 metropolitan areas
included in the CEWG.
In
Kings County, Washington, a recently completed survey of
young men who have sex with men showed that MDMA was among
the frequently used drugs (20 percent of the sample).
In
Boston, a 1996-97 survey of public schools in Boston found
that about 14 percent of male and 7 percent of female 12th
graders had used MDMA during their lifetime.
Information
about MDMA from other CEWG areas include the following:
In
Atlanta, MDMA is reported as a popular stimulant.
In
Chicago, its use is common in the rave and club scenes,
especially in the North Side.
In
Miami, large-scale sales of drugs such as MDMA are
occurring at raves.
In
Delaware, it is available across the state, particularly
in college towns.
National
Household Survey on Drug Abuse (NHSDA)
Each
year, the NHSDA reports on the nature and extent of drug use
among the American household population aged 12 and older.
The 1998 survey found that an estimated 1.5 percent (3.4
million) of Americans at least 12 years old had used MDMA at
least once during their lifetime. By age group, the heaviest
use (5 percent or 1.4 million people) was reported for those
between 18 and 25 years old.
Monitoring
the Future Study (MTF)
In
1996, the MTF began to collect data on MDMA use among
students. Rates of use remained relatively stable from 1996
to 1998. In 1998, 5.8 percent of 12th graders, 5.1 percent
of 10th graders, and 2.7 percent of 8th graders had used
MDMA at least once in their lives.
Ecstasy
Use by Students, 1998:
Monitoring the Future Study
8th-Graders
10th-Graders
12th-Graders
Used
in Lifetime
2.7%
5.1%
5.8%
Used
in Past Year
1.8
3.3
3.6
Used
in Past Month
0.9
1.3
1.5
"Lifetime"
refers to use at least once during a respondents lifetime.
"Past year" refers to an individuals drug use at
least once during the year preceding their response to the
survey. "Past month" refers to an individuals
drug use at least once during the month preceding their
response to the survey.
Information on this page
courtesy of National Institute on Drug Abuse.